{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:25:27Z","timestamp":1774592727863,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12020-022-03041-8","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:14:26Z","timestamp":1648534466000},"page":"601-611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of excluding hyperglycemia from international diabetes federation metabolic syndrome diagnostic criteria on prevalence of the syndrome and its association with microvascular complications, in adult patients with type 1 diabetes"],"prefix":"10.1007","volume":"76","author":[{"given":"Edurne","family":"Lecumberri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-9397","authenticated-orcid":false,"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhonatan","family":"Qui\u00f1ones Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alonso D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fern\u00e1ndez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Dorado Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"issue":"5","key":"3041_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"K.G. Alberti, P. Zimmet, J. Shaw, Metabolic syndrome\u2013a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med 23(5), 469\u2013480 (2006)","journal-title":"Diabet. Med"},{"issue":"3","key":"3041_CR2","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.diabres.2012.02.004","volume":"96","author":"CM Girgis","year":"2012","unstructured":"C.M. Girgis, B.D. Scalley, K.E. Park, Utility of the estimated glucose disposal rate as a marker of microvascular complications in young adults with type 1 diabetes. Diabetes Res Clin. Pr. 96(3), e70\u2013e72 (2012)","journal-title":"Diabetes Res Clin. Pr."},{"issue":"1","key":"3041_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13098-021-00641-8","volume":"13","author":"R Belete","year":"2021","unstructured":"R. Belete, Z. Ataro, A. Abdu, M. Sheleme, Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 13(1), 25 (2021)","journal-title":"Diabetol. Metab. Syndr."},{"issue":"12","key":"3041_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1111\/dom.13009","volume":"19","author":"A Brown","year":"2017","unstructured":"A. Brown, N. Guess, A. Dornhorst, S. Taheri, G. Frost, Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done? Diabetes Obes. Metab. 19(12), 1655\u201368. (2017)","journal-title":"Diabetes Obes. Metab."},{"issue":"9491","key":"3041_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"K.G. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome\u2013a new worldwide definition. Lancet 366(9491), 1059\u20131062 (2005)","journal-title":"Lancet"},{"issue":"6","key":"3041_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5539\/gjhs.v5n6p142","volume":"5","author":"D Yadav","year":"2013","unstructured":"D. Yadav, S. Mahajan, S.K. Subramanian, P.S. Bisen, C.H. Chung, G.B. Prasad, Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob. J. Health Sci. 5(6), 142\u2013155 (2013)","journal-title":"Glob. J. Health Sci."},{"issue":"2","key":"3041_CR7","doi-asserted-by":"publisher","first-page":"e3088","DOI":"10.1002\/dmrr.3088","volume":"35","author":"L Nattero-Ch\u00e1vez","year":"2019","unstructured":"L. Nattero-Ch\u00e1vez, S. Redondo L\u00f3pez, S. Alonso D\u00edaz, M. Garnica Ure\u00f1a, E. Fern\u00e1ndez-Dur\u00e1n, H.F. Escobar-Morreale et al. The peripheral atherosclerotic profile in patients with type 1 diabetes warrants a thorough vascular assessment of asymptomatic patients. Diabetes Metab. Res Rev. 35(2), e3088 (2019)","journal-title":"Diabetes Metab. Res Rev."},{"key":"3041_CR8","doi-asserted-by":"crossref","unstructured":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021;44(Suppl 1):S15-S33.","DOI":"10.2337\/dc21-S002"},{"issue":"27","key":"3041_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-4-27","volume":"4","author":"RF Gillum","year":"2005","unstructured":"R.F. Gillum, C.T. Sempos, Ethnic variation in validity of classification of overweight and obesity using self-reported weight and height in American women and men: the Third National Health and Nutrition Examination Survey. Nutr. J. 4(27), 27 (2005)","journal-title":"Nutr. J."},{"issue":"Suppl 1","key":"3041_CR10","first-page":"S151","volume":"44","author":"11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021.","year":"2021","unstructured":"11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021. Diabetes Care 44(Suppl 1), S151\u2013S167 (2021)","journal-title":"Diabetes Care"},{"issue":"7","key":"3041_CR11","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1210\/jc.2018-02729","volume":"104","author":"L Nattero-Ch\u00e1vez","year":"2019","unstructured":"L. Nattero-Ch\u00e1vez, S. Redondo L\u00f3pez, S. Alonso D\u00edaz, M. Garnica Ure\u00f1a, E. Fern\u00e1ndez-Dur\u00e1n, H.F. Escobar-Morreale et al. Association of cardiovascular autonomic dysfunction with peripheral arterial stiffness in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 104(7), 2675\u201384. (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3041_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"R. Pop-Busui, A.J. Boulton, E.L. Feldman, V. Bril, R. Freeman, R.A. Malik et al. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care 40(1), 136\u201354. (2017)","journal-title":"Diabetes Care"},{"issue":"4","key":"3041_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"KV Williams","year":"2000","unstructured":"K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49(4), 626\u2013632 (2000)","journal-title":"Diabetes"},{"issue":"1","key":"3041_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13300-019-00729-5","volume":"11","author":"D \u0160imonien\u0117","year":"2020","unstructured":"D. \u0160imonien\u0117, A. Plat\u016bkiene, E. Prakapien\u0117, L. Radzevi\u010dien\u0117, D. Veli\u010dkiene, Insulin resistance in type 1 diabetes mellitus and its association with patient\u2019s micro- and macrovascular complications, sex hormones, and other clinical data. Diabetes Ther. 11(1), 161\u201374 (2020)","journal-title":"Diabetes Ther."},{"issue":"12","key":"3041_CR15","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.2337\/dc06-0942","volume":"29","author":"R Bonadonna","year":"2006","unstructured":"R. Bonadonna, D. Cucinotta, D. Fedele, G. Riccardi, A. Tiengo, The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 29(12), 2701\u20132707 (2006)","journal-title":"Diabetes Care"},{"issue":"3","key":"3041_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","volume":"30","author":"ES Kilpatrick","year":"2007","unstructured":"E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the Diabetes Control and Complications Trial. Diabetes Care 30(3), 707\u201312. (2007)","journal-title":"Diabetes Care"},{"issue":"16","key":"3041_CR17","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20131645 (2009)","journal-title":"Circulation"},{"issue":"5","key":"3041_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2337\/dc06-2053","volume":"30","author":"G Pambianco","year":"2007","unstructured":"G. Pambianco, T. Costacou, T.J. Orchard, The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30(5), 1248\u20131254 (2007)","journal-title":"Diabetes Care"},{"key":"3041_CR19","doi-asserted-by":"crossref","unstructured":"J.J. Chillar\u00f3n, J.A. Flores-Le-Roux, A. Goday, D. Benaiges, M.J. Carrera, J. Puig, et al. [Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors]. Rev Esp Cardiol 63(4), 423\u20139 (2010)..","DOI":"10.1016\/S1885-5857(10)70091-8"},{"issue":"3","key":"3041_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.diabres.2007.06.007","volume":"78","author":"TM Davis","year":"2007","unstructured":"T.M. Davis, D.G. Bruce, W.A. Davis, Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin. Pr. 78(3), 412\u2013417 (2007)","journal-title":"Diabetes Res Clin. Pr."},{"issue":"8","key":"3041_CR21","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2337\/diacare.28.8.2019","volume":"28","author":"LM Thorn","year":"2005","unstructured":"L.M. Thorn, C. Forsblom, J. Fagerudd, M.C. Thomas, K. Pettersson-Fernholm, M. Saraheimo et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28(8), 2019\u201324. (2005)","journal-title":"Diabetes Care"},{"issue":"3","key":"3041_CR22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.dsx.2019.03.036","volume":"13","author":"HM Soliman","year":"2019","unstructured":"H.M. Soliman, Y.O. Mosaad, A. Ibrahim, The prevalence and the clinical profile of metabolic syndrome in children and adolescents with Type 1 diabetes. Diabetes Metab. Syndr. 13(3), 1723\u20131726 (2019)","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"3041_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.metabol.2013.10.002","volume":"63","author":"JJ Chillar\u00f3n","year":"2014","unstructured":"J.J. Chillar\u00f3n, J.A. Flores Le-Roux, D. Benaiges, J. Pedro-Botet, Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism 63(2), 181\u2013187 (2014)","journal-title":"Metabolism"},{"issue":"2","key":"3041_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"JQ Purnell","year":"2013","unstructured":"J.Q. Purnell, B. Zinman, J.D. Brunzell, The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study (DCCT\/EDIC) study. Circulation 127(2), 180\u2013187 (2013)","journal-title":"Circulation"},{"issue":"7","key":"3041_CR25","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","volume":"56","author":"SJ Cleland","year":"2013","unstructured":"S.J. Cleland, B.M. Fisher, H.M. Colhoun, N. Sattar, J.R. Petrie, Insulin resistance in type 1 diabetes: what is \u2018double diabetes\u2019 and what are the risks? Diabetologia 56(7), 1462\u201370. (2013)","journal-title":"Diabetologia"},{"issue":"11","key":"3041_CR26","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ejcn.2016.111","volume":"70","author":"SR Mirhafez","year":"2016","unstructured":"S.R. Mirhafez, M. Ebrahimi, M. Saberi Karimian, A. Avan, M. Tayefi, A. Heidari-Bakavoli et al. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects. Eur. J. Clin. Nutr. 70(11), 1298\u2013304. (2016)","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"3041_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/01.CIR.0000136581.59584.0E","volume":"110","author":"MK Rutter","year":"2004","unstructured":"M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D\u2019Agostino Sr., P.W. Wilson, C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110(4), 380\u2013385 (2004)","journal-title":"Circulation"},{"issue":"5","key":"3041_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/jdi.12650","volume":"8","author":"AM Stino","year":"2017","unstructured":"A.M. Stino, A.G. Smith, Peripheral neuropathy in prediabetes and the metabolic syndrome. J. Diabetes Investig. 8(5), 646\u201355. (2017)","journal-title":"J. Diabetes Investig."},{"issue":"4","key":"3041_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"S. Tesfaye, N. Chaturvedi, S.E. Eaton, J.D. Ward, C. Manes, C. Ionescu-Tirgoviste et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med 352(4), 341\u2013350 (2005)","journal-title":"N. Engl. J. Med"},{"issue":"38","key":"3041_CR30","doi-asserted-by":"publisher","first-page":"e12433","DOI":"10.1097\/MD.0000000000012433","volume":"97","author":"Y Zhou","year":"2018","unstructured":"Y. Zhou, C. Wang, K. Shi, X. Yin, Relation of metabolic syndrome and its components with risk of diabetic retinopathy: A meta-analysis of observational studies. Medicine 97(38), e12433 (2018)","journal-title":"Medicine"},{"issue":"4","key":"3041_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2337\/diacare.29.04.06.dc05-2011","volume":"29","author":"CH Saely","year":"2006","unstructured":"C.H. Saely, L. Koch, F. Schmid, T. Marte, S. Aczel, P. Langer et al. Adult treatment panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29(4), 901\u2013907 (2006)","journal-title":"Diabetes Care"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:40:09Z","timestamp":1653997209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3041"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03041-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the authors gave their consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors gave their consent. All participants gave written informed consent before being included in the study. Participants did not receive any economic compensation for their participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The Hospital\u2019s Ethics Committee approved the project.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}